(19)

(11)

EP 4 680 265 A1

(12)

(43) Date of publication: 21.01.2026 Bulletin 2026/04 (21) Application number: 24771718.4 (22) Date of filing: 14.03.2024

(51) International Patent Classification (IPC):  A61K 38/26(2006.01) A61K 9/20(2006.01) A61K 47/18(2017.01) A61K 47/38(2006.01) A61P 3/10(2006.01) A61K 9/00(2006.01) A61K 47/12(2006.01) A61K 47/32(2006.01) A61P 1/16(2006.01) A61P 13/12(2006.01) (52) Cooperative Patent Classification (CPC): A61P 3/10; A61K 38/26; A61K 47/12; A61P 13/12; A61K 47/18; A61P 1/16; A61K 9/2013; A61K 9/2027; A61K 9/2054 (86) International application number: PCT/US2024/019883 (87) International publication number: WO 2024/192219 (19.09.2024 Gazette 2024/38)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 15.03.2023 US 202363490512 P (71) Applicant: Viking Therapeutics, Inc. San Diego, CA 92121 (US)	(72) Inventors: LIAN, Brian San Diego, California 92121 (US) BARKER, Geoffrey E. San Diego, California 92121 (US) BARNES, Maureen San Diego, California 92121 (US) YAGIZ, Kader San Diego, California 92121 (US) GONZALEZ, Jake San Diego, California 92121 (US) (74) Representative: Heller, Benjamin Henry  Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)